154 related articles for article (PubMed ID: 21091148)
21. Major hemorrhagic and thromboembolic complications in patients with mechanical heart valves receiving oral anticoagulant therapy.
Trzeciak P; Zembala M; Poloński L
Heart Surg Forum; 2010 Apr; 13(2):E80-5. PubMed ID: 20444682
[TBL] [Abstract][Full Text] [Related]
22. Acute bleeding complications in patients after hematopoietic stem cell transplantation with prophylactic platelet transfusion triggers of 10 x 10(9) and 20 x 10(9) per L.
Nevo S; Fuller AK; Hartley E; Borinsky ME; Vogelsang GB
Transfusion; 2007 May; 47(5):801-12. PubMed ID: 17465944
[TBL] [Abstract][Full Text] [Related]
23. Therapy insight: Vascular complications in patients with inflammatory bowel disease.
Koutroubakis IE
Nat Clin Pract Gastroenterol Hepatol; 2005 Jun; 2(6):266-72. PubMed ID: 16265230
[TBL] [Abstract][Full Text] [Related]
24. Symptomatic venous thromboembolism and thrombophilic status in adult acute leukemia: a single-center experience of 114 patients at diagnosis.
Melillo L; Grandone E; Colaizzo D; Cappucci F; Valvano MR; Cascavilla N
Acta Haematol; 2007; 117(4):215-20. PubMed ID: 17237616
[TBL] [Abstract][Full Text] [Related]
25. Peripheral arterial ischemic events in cancer patients.
Sanon S; Lenihan DJ; Mouhayar E
Vasc Med; 2011 Apr; 16(2):119-30. PubMed ID: 21112902
[TBL] [Abstract][Full Text] [Related]
26. Bleeding and thrombotic complications of kidney disease.
Pavord S; Myers B
Blood Rev; 2011 Nov; 25(6):271-8. PubMed ID: 21872374
[TBL] [Abstract][Full Text] [Related]
27. A multicenter pilot-randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation.
Webert KE; Cook RJ; Couban S; Carruthers J; Lee KA; Blajchman MA; Lipton JH; Brandwein JM; Heddle NM
Transfusion; 2008 Jan; 48(1):81-91. PubMed ID: 17894791
[TBL] [Abstract][Full Text] [Related]
28. Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.
Berger PB; Bhatt DL; Fuster V; Steg PG; Fox KA; Shao M; Brennan DM; Hacke W; Montalescot G; Steinhubl SR; Topol EJ;
Circulation; 2010 Jun; 121(23):2575-83. PubMed ID: 20516378
[TBL] [Abstract][Full Text] [Related]
29. Hypercoagulability and tissue factor gene upregulation in hematologic malignancies.
Falanga A; Barbui T; Rickles FR
Semin Thromb Hemost; 2008 Mar; 34(2):204-10. PubMed ID: 18645927
[TBL] [Abstract][Full Text] [Related]
30. The risk of bleeding in thrombocytopenic patients with acute myeloid leukemia.
Webert K; Cook RJ; Sigouin CS; Rebulla P; Heddle NM
Haematologica; 2006 Nov; 91(11):1530-7. PubMed ID: 17043016
[TBL] [Abstract][Full Text] [Related]
31. Thromboembolic and/or bleeding complications in patients under oral anticoagulation followed at a tertiary hospital.
Pelicano N; Branco LM; Pinto A; Sá A; Timóteo AT; Feliciano J; Fiarresga A; Agapito AF; Palma MC; Quininha J
Rev Port Cardiol; 2005; 24(7-8):957-68. PubMed ID: 16240682
[TBL] [Abstract][Full Text] [Related]
32. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.
Michiels JJ; Berneman Z; Van Bockstaele D; van der Planken M; De Raeve H; Schroyens W
Semin Thromb Hemost; 2006 Apr; 32(3):174-207. PubMed ID: 16673274
[TBL] [Abstract][Full Text] [Related]
33. Incidence and pathogenesis of thrombosis in hematologic malignancies.
Kwaan HC; Vicuna B
Semin Thromb Hemost; 2007 Jun; 33(4):303-12. PubMed ID: 17525887
[TBL] [Abstract][Full Text] [Related]
34. Relation of platelet abnormalities to thrombosis and hemorrhage in chronic myeloproliferative disorders.
Wehmeier A; Südhoff T; Meierkord F
Semin Thromb Hemost; 1997; 23(4):391-402. PubMed ID: 9263357
[TBL] [Abstract][Full Text] [Related]
35. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events.
MacLaren R; Bond CA
Pharmacotherapy; 2009 Jul; 29(7):761-8. PubMed ID: 19558249
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for venous thromboembolism in children.
Gerotziafas GT
Int Angiol; 2004 Sep; 23(3):195-205. PubMed ID: 15765033
[TBL] [Abstract][Full Text] [Related]
37. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
[TBL] [Abstract][Full Text] [Related]
38. Significance of fibrinogen, D-dimer, and LDH levels in predicting the risk of bleeding in patients with acute promyelocytic leukemia.
Kim DY; Lee JH; Lee JH; Kim SD; Lim SN; Choi Y; Lee YS; Kang YA; Seol M; Jeon M; Kim JY; Lee KH; Lee YJ; Lee KH
Leuk Res; 2011 Feb; 35(2):152-8. PubMed ID: 20554322
[TBL] [Abstract][Full Text] [Related]
39. Acute bleeding and thrombocytopenia after bone marrow transplantation.
Nevo S; Enger C; Hartley E; Borinsky ME; Swan V; Fuller AK; Braine HG; Kickler TS; George JN; Vogelsang GB
Bone Marrow Transplant; 2001 Jan; 27(1):65-72. PubMed ID: 11244439
[TBL] [Abstract][Full Text] [Related]
40. [The HITT syndrome: heparin-induced thrombocytopenia and thrombosis as a cause of paradoxically occurring thromboembolisms].
Lamme SJ; de Rooij PD; Huijgens PC; Rauwerda JA
Ned Tijdschr Geneeskd; 1994 Jan; 138(4):189-93. PubMed ID: 8107919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
